Hims & Hers Health, Inc. (HIMS) has emerged as a transformative player in the personalized healthcare market, showcasing robust growth in 2024. Shares of the company have risen 43% in the past month, significantly outperforming the industry’s growth of 5.5%.In the third quarter, the company reported revenues of $401.6 million, reflecting a 77% year-over-year increase. Earnings per share (EPS) of 32 cents met the analyst expectations. The company now boasts over 2 million subscribers, of which more than 50% ...